Prasugrel versus Ticagrelor in Acute Coronary Syndromes

医学 替卡格雷 内科学 心脏病学 普拉格雷 急性冠脉综合征 心肌梗塞 冠状动脉疾病 冠心病 氯吡格雷
作者
Elmir Ömerovic,Sasha M. Koul,Jonas Andersson,J. Pontén,Fredrik Björklund,Robert Kastberg,Mila Sun,Charlotta E. A. Ljungman,Ole Fröbert,Kristian Bolin,Kristofer Skoglund,Carl-David Dolata,Mats Birgander,Helena Wikström,Truls Råmunddal,Oskar Angerås,Pétur Pétursson,David Erlinge,Björn Redfors
出处
期刊:The New England Journal of Medicine [Massachusetts Medical Society]
被引量:2
标识
DOI:10.1056/nejmoa2609057
摘要

BACKGROUND: Whether prasugrel or ticagrelor should be the preferred P2Y12 inhibitor for patients with an acute coronary syndrome is uncertain. METHODS: We conducted a registry-based, open-label, stepped-wedge, cluster-randomized trial in Sweden involving adults who had undergone percutaneous coronary intervention for an acute coronary syndrome. Seven regions, grouped into three clusters, switched from ticagrelor to prasugrel as the default P2Y12 inhibitor in a randomized sequence across four 9-month periods between 2021 and 2024. The primary end point was a composite of death from any cause, fatal or nonfatal myocardial infarction, or fatal or nonfatal stroke through 1 year, as ascertained from national registries. In the intention-to-treat analysis, a mixed model adjusted for cluster and calendar time was used to obtain a policy-level estimate. RESULTS: A total of 17,095 patients were enrolled; 9444 received care under the default ticagrelor policy, and 7651 received care under the default prasugrel policy. The mean (±SD) age of the patients was 69.8±11.5 years, and 36.8% were at least 75 years old; 27.8% of the patients were female. A total of 39.4% presented with ST-segment elevation myocardial infarction (STEMI), 43.7% with non-STEMI, and 16.8% with unstable angina. At 1 year, a primary end-point event had occurred in 11.8% of the patients in the ticagrelor-policy group and in 11.1% of those in the prasugrel-policy group (adjusted odds ratio [prasugrel vs. ticagrelor], 0.90; 95% confidence interval [CI], 0.77 to 1.06), and major bleeding had occurred in 4.4% and 4.2%, respectively (adjusted odds ratio, 0.80; 95% CI, 0.64 to 0.99). CONCLUSIONS: In an unselected population of patients with an acute coronary syndrome who had undergone percutaneous coronary intervention, the risk of ischemic events was not lower with a default prasugrel policy than with a default ticagrelor policy. (Funded by Region Västra Götaland; SWITCH-SWEDEHEART ClinicalTrials.gov number, NCT05183178.).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
只道寻常完成签到,获得积分10
1秒前
Lily完成签到,获得积分10
1秒前
封典完成签到,获得积分10
1秒前
感谢负责的代亦转发科研通微信,获得积分50
2秒前
zh完成签到 ,获得积分10
2秒前
2秒前
valiente完成签到,获得积分10
2秒前
wenli完成签到,获得积分10
2秒前
Bryant完成签到,获得积分10
3秒前
三脸茫然完成签到 ,获得积分0
3秒前
xxx完成签到 ,获得积分10
3秒前
StarXG完成签到,获得积分10
3秒前
4秒前
wqwq69完成签到,获得积分10
4秒前
4秒前
liliang316完成签到,获得积分10
4秒前
挚友发布了新的文献求助20
4秒前
熊博士完成签到,获得积分10
4秒前
感谢无辜的傲芙转发科研通微信,获得积分50
5秒前
whyme完成签到,获得积分10
5秒前
Vision完成签到,获得积分10
5秒前
nihao完成签到,获得积分10
5秒前
了凡完成签到,获得积分10
6秒前
本尼脸上褶子完成签到 ,获得积分10
6秒前
天天快乐的应助被挽风风风风采纳,获得10
6秒前
张乐完成签到,获得积分10
6秒前
一叶孤舟完成签到,获得积分10
7秒前
xzx完成签到,获得积分10
7秒前
7秒前
跳跃指甲油完成签到 ,获得积分10
7秒前
感谢干净沉鱼转发科研通微信,获得积分50
7秒前
TQ完成签到,获得积分10
7秒前
淡然胡萝卜完成签到,获得积分10
7秒前
万柏祺完成签到,获得积分10
8秒前
素雅完成签到,获得积分10
8秒前
简单的一一完成签到,获得积分10
9秒前
蔗不对吧完成签到,获得积分10
9秒前
聂落雁完成签到,获得积分10
9秒前
无患子完成签到,获得积分10
9秒前
感谢梁梁梁梁转发科研通微信,获得积分50
10秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8173463
求助须知:如何正确求助?哪些是违规求助? 9565690
关于积分的说明 21781315
捐赠科研通 7767647
什么是DOI,文献DOI怎么找? 3431597
关于科研通互助平台的介绍 2555855
邀请新用户注册赠送积分活动 2476808